IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC

NCT03378297 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Metformin
DRUG: Acetylsalicylic acid
DRUG: Olaparib
DRUG: Letrozole

Sponsor

Haukeland University Hospital